
    
      This is a single-center, in-patient, treatment sequence-randomized, single-blind SD and MD
      crossover study in 27 healthy adult male and female subjects. Subjects will be admitted to
      the clinic on Day-1 and discharged the morning of Day 5 of each treatment period. Subjects
      will be on a standard diet during each inpatient treatment period; study drug will be
      administered in the fasted state for PK assessments on Days 1 and 4 of each treatment period.
      Subjects will have a follow-up phone call 7 to 10 days after the last dose in Period 3. There
      will be a 6 to 8 day washout between the last dose in Period 1 and the first dose in Period
      2, and between the last dose in Period 2 and the first dose in Period 3.
    
  